Pricing Log in Create free account

Cardiol Therapeutics Inc. (CRDL) vs Organogenesis (ORGO)

Cardiol Therapeutics Inc. and Organogenesis are both Drug Manufacturers Specialty & Generic companies. Cardiol Therapeutics Inc. and Organogenesis are of similar size ($111.8M and $108.1M). Cardiol Therapeutics Inc. has the higher net margin (0.00% vs −43.5%) and the higher return on invested capital (0.00% vs −52.2%). Across the 15 metrics below, Organogenesis leads on 9 and Cardiol Therapeutics Inc. on 6.

Valuation

Metric CRDL ORGO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S n/m 0.30 2.08
P/B 6.16 0.89 1.79
Price to free cash flow n/m 30.18 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales n/m 0.27 2.87
Earnings yield (26.88%) (145.78%) (15.94%)
Free cash flow yield (16.13%) 3.31% 0.00%

Profitability

Metric CRDL ORGO Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 65.56% 53.51%
Operating margin 0.00% (24.45%) 0.00%
Net margin 0.00% (43.50%) (2.45%)
Free cash flow margin 0.00% 1.01% 0.00%
Return on equity (171.13%) (81.71%) (0.80%)
Return on assets (124.40%) (34.86%) (1.67%)
Return on invested capital 0.00% (52.15%) 0.00%

Growth

Metric CRDL ORGO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (24.33%) 5.22%
EPS growth (last fiscal year) 24.32% 1,600.00% 42.91%
Revenue growth, 5-year CAGR — 10.77% 7.24%
Net income growth, 5-year CAGR 0.00% 3.04% 0.00%

Health

Metric CRDL ORGO Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.09 0.04
Current ratio 5.55 3.32 2.41
Net debt to EBITDA 0.62 (1.14) 1.01

Dividend

Metric CRDL ORGO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric CRDL ORGO Drug Manufacturers Specialty & Generic median
Market cap 111.79m 108.08m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack